Status:

NOT_YET_RECRUITING

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

Lead Sponsor:

Prisma Health-Upstate

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Tobacco-flavored EC

Sweet-Cooling EC

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking bu...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Age ≥21 years
  • Smoke ≥5 CPD for ≥1 year
  • Daily CC smoker
  • Willing to switch to EC
  • Exhaled CO ≥6 ppm
  • Diagnosed with OUD
  • Stable on bupropion treatment
  • In good physical and mental health
  • Able to use a smartphone
  • Willing to participate in all study components
  • Able to provide informed consent Exclusion Criteria
  • Interested in quitting CC (contemplation stage of change)
  • Use of EC on ≥4 of the past 30 days
  • Use of other tobacco products (e.g., cigars, smokeless tobacco) on ≥9 days of the past 30 days
  • Use of nicotine replacement therapy, smoking cessation medication, or a cessation attempt in the past 30 days
  • Hypertension
  • Medical condition that would contraindicate participation
  • Meet DSM-V criteria for major depressive episode, psychotic episode, or manic episode
  • Current suicidal ideation or suicide attempt in the past year
  • Psychiatric hospitalization in the past year
  • Contemplating pregnancy, currently pregnant, or breastfeeding
  • Unable to speak and/or read English

Exclusion

    Key Trial Info

    Start Date :

    January 5 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 4 2030

    Estimated Enrollment :

    90 Patients enrolled

    Trial Details

    Trial ID

    NCT07202039

    Start Date

    January 5 2026

    End Date

    February 4 2030

    Last Update

    October 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Addiction Medicine Center

    Greenville, South Carolina, United States, 29605